Skip to main content
Revista Española de Quimioterapia logoLink to Revista Española de Quimioterapia
letter
. 2022 Dec 2;36(1):103–106. doi: 10.37201/req/082.2022

Could Mycoplasma genitalium be involved in chronic granulomatous orchiepididymits? Case report and literature review

Domingo Fernández Vecilla 1,3,, Julia Aragón Díez 1,3, María Carmen Nieto Toboso 1,3, Jaume Rosselló Soria 2,3, José Luis Díaz de Tuesta del Arco 1,3
PMCID: PMC9910672  PMID: 36458723

Sir,

Mycoplasma genitalium is the smallest known self-replicating bacterium, presenting a slow and fastidious growth. It was first isolated from urethral swabs of two symptomatic men with urethritis in 1980 [1]. It lacks a cell wall and therefore cannot be detected by Gram staining. M. genitalium is predominantly found in the genitourinary tract of both sexes. It establishes infection intracellularly, which together with the antigenic and phase variation of the proteins expressed on its surface manages to evade the adaptive immune system [2].

A 33-year-old male patient presented to his physician for left testicular pain of more than one year’s duration, related to certain movements. The patient had no external data of inflammation, urethral discharge, dysuria, hemospermia or pain on ejaculation. As medical history, the patient had suffered an episode three years earlier of left epididymitis with an unidentified cause diagnosed by ultrasound (enlarged epididymis, with marked vascularization in the color doppler study, while the testicle showed normal structure and vascularization) and for which he received analgesic treatment, but no antibiotics. On examination of the left testicle, the lower pole was palpated with a mass of approximately 1-2 cm hard and painless. Ultrasound showed a 1.2 cm hypoechogenic solid mass with slight peripheral vascular enhancement (Figure 1), so the study was complemented with a computed tomography (CT) and blood tests with tumor markers. In the blood test, both chorionic gonadotropin beta subunit and alpha 1 fetoprotein were in normal ranges, while the CT scan of the chest, abdomen and pelvis ruled out tumor dissemination.

Figure 1.

Figure 1

A hypoechogenic solid mass of rounded morphology measuring 12 mm with slight peripheral vascular enhancement is visualized.

After evaluation of the case, left radical orchiectomy via inguinal route was conducted. The surgical sample was sent to anatomic pathology for study and a 1.6 x 1.1 cm lesion of yellowish-white coloration and necrotic-purulent appearance was observed. Microscopically (Figure 2), a necrotizing, impaling and exudative granulomatous lesion was observed, while in the rest of the epididymis chronic inflammatory changes with suppurative flare-up and images of spermatogenic granuloma of long evolution were observed. Grocott, Ziehl and Warthin-Starry techniques (which can detect fungi, mycobacteria and Helicobacter pylori or spirochetes, respectively), together with immunohistochemical markers for germinal lesion (OCT-4 and SALL-4), as well as PLAP, D2-40 and CK AE1-AE3, were negative.

Figure 2.

Figure 2

A: Hematoxylin-Eosin stain. 2x. Histological slides showing testicular parenchima composed by seminiferous tubules. Contiguous to the parenchima, a thick well defined fibrotic layer with mixed inflamation, containing an exudative necrotic granuloma.

B: Immunohistochemistry. 2x – Histiocytic palisade (↓) of the granulomatous wall is observed by CD163 positive staining.

DNA eluate was obtained using the Cobas© DNA Sample Preparation Kit panel (Roche Diagnostics, Basel, Switzerland) from the lesion to perform PCR of Mycobacterium tuberculosis using the GenoType Mycobacteria Direct panel (Hain Lifescience, Nehren, Germany), which allows us, by amplification of 23S rRNA, the detection of M. tuberculosis Complex, Mycobacterium avium, Mycobacterium intracellulare, Mycobacterium kansasii and Mycobacterium malamoense, with negative results. The STI Essential Assay AllpexTM panel (Seegene, Seoul, South Korea) that detects 7 pathogens related to sexually transmitted infections (Chlamydia trachomatis, Mycoplasma genitalium, Mycoplasma hominis, Neisseria gonorrhoeae, Trichomonas vaginalis, Ureaplasma parvum and Ureaplasma urealyticum) was also performed, detecting M. genitalium with Ct (cycle threshold) values of 21. A semen sample was sent 1 month after this study and the STI Essntial Assay Allplex© panel again detected M. genitalium, but this time with Ct values of 33. In addition, the ResistancePlus© MG FleXible panel was performed on the Gen-eXpert system (Cepheid, California, USA), which detects both M. genitalium and macrolide resistance mediated by mutations in the 23S rRNA gene, with detection of the microorganism, but without detection of the mutation.

Following this result, the patient was treated with 100 mg/12 h of doxycycline for 7 days, followed by 1 g of azithromycin on the 8th day and 500 mg the next two days. The patient was evaluated again 5 weeks later and was found to be asymptomatic.

Granulomatous orchitis is a pathologic syndrome attributed to different etiologic factors, with a common histologic feature in all of them, granulomatous inflammation in the testis. Because granulomatous inflammation of the testis can be seen in many conditions, the diagnosis is one of exclusion. Because the clinical presentation and sonographic findings are often suspicious for malignancy, the specimen for pathologic examination is usually an orchiectomy specimen. Significant associated medical history includes testicular trauma or surgical procedure, history of tuberculosis, urinary tract infections, and epididymitis, among others [3,4].

Enterobacteriaceae such as Escherichia coli or Salmonella enteritidis, Actinomyces israeli or sexually transmitted microorganisms such as N. gonorrhoeae or C. trachomatis are some of the possible causative agents of epididymitis, orchitis or non-granulomatous orchiepidididymitis [5-7]. Within granulomatous orchioepididymitis, the infectious cause is one of the possible differential diagnoses along with idiopathic, tumor or autoimmune causes [4,7]. Making a differential diagnosis is fundamental and M. tuberculosis, Treponema pallidum, Mycobacterium leprae, brucellosis or rarer infectious etiologies such as fungal (blastomycosis, coccidiomycosis, histoplasmosis or cryptococcosis) or parasitic (filariasis or Schistosoma spp.) should be considered when patients live in or travel from endemic areas [7-10]. Following the increase in people migrating from countries with a high incidence of tuberculosis disease and the increase in the population of immunocompromised patients, M. tuberculosis has to be taken into account. Genitourinary tuberculosis is one of the most frequent extrapulmonary presentations after lymphatic tuberculosis. Although epididymal involvement is frequent, very few cases occur in the form of orchitis [7,9].

M. genitalium has emerged in recent decades as a sexually transmitted pathogen, in fact, it is estimated to account for 10-35% of non-gonococcal urethritis [11,12] Due to its fastidious growth, culture is limited to research laboratories and reference centers and clinical diagnosis is usually performed by molecular methods. In a 2018 meta-analysis, its prevalence was observed to vary from 1.3% in developed countries to 3.9% in developing countries, although this data could be biased, as the detection of asymptomatic infections would be more common in patients who frequent centers or consultations specializing in sexually transmitted infections [13,14]. In this same meta-analysis, the prevalence by risk groups was estimated at 0.9% in pregnant women, 3.2% in men who have sex with men and 15.9% in sex workers. As M. genitalium infection is not a notifiable disease in Spain, the epidemiological data available are based on case series published at different times and in different areas, ranging from 2.4% to 9% in men and from 0.96% to 13% in women [14-16].

In many cases, detection of M. genitalium does not correlate with symptoms or signs of genital tract infection such as urethritis, abnormal vaginal discharge, or pelvic pain, suggesting that asymptomatic infection may not be pathogenic. Further studies should be done to determine whether asymptomatic infection could cause long-term complications. Previously, this microorganism has been associated with acute or chronic urethritis, proctitis or even epididymitis, while its association with prostatitis is still unclear [12,17]. This is the first time that M. genitalium is implicated in a case of orchiepidididymitis, although we cannot discriminate whether this microorganism was the cause of epididymitis at first and chronified causing the granulomatous lesion or was responsible for the suppurative flare-up of the pre-existing lesion.

Granulomatous inflammation of the testis can be seen in many pathologies, so a thorough differential diagnosis is essential. The advance of molecular techniques in recent years has changed microbiology with rapid identification of multiple pathogens, improving the screening of various infections. The relevance of M. genitalium as a sexually transmitted pathogen has increased in the last decades being demonstrated its implication in urethritis, proctitis or epididymitis. More studies and reports are needed to demonstrate its possible pathogenicity as a cause of other different conditions.

FUNDING

Translation financed by the OSI Bilbao-Basurto research commission.

CONFLICT OF INTEREST

The authors declare no conflict of interest.

References

  • 1.Tully JG, Taylor-Robinson D, Cole RM, Rose DL. A newly discovered mycoplasma in the human urogenital tract. Lancet. 1981. Jun 13;1(8233):1288-91. doi: 10.1016/s0140-6736(81)92461-2. [DOI] [PubMed] [Google Scholar]
  • 2.Pinto-Sander N, Soni S. Mycoplasma genitalium infection. BMJ. 2019. Oct 18;367:l5820. doi: 10.1136/bmj.l5820. [DOI] [PubMed] [Google Scholar]
  • 3.Perimenis P, Athanasopoulos A, Venetsanou-Petrochilou C, Barbalias G. Idiopathic granulomatous orchitis. Eur Urol. 1991;19(2):118-20. doi: 10.1159/000473598. [DOI] [PubMed] [Google Scholar]
  • 4.Peyrí Rey E, Riverola Manzanilla A, Cañas Tello MA. Orquitis granulomatosa idiopática bilateral [Bilateral idiopathic granulomatous orchitis]. Actas Urol Esp. 2008;32(4):461-3. Spanish. doi: 10.1016/s0210-4806(08)73864-6. [DOI] [PubMed] [Google Scholar]
  • 5.Lin CY, Jwo SC, Lin CC. Primary testicular actinomycosis mimicking metastatic tumor. Int J Urol. 2005;12(5):519-21. doi: 10.1111/j.1442-2042.2005.01092.x. [DOI] [PubMed] [Google Scholar]
  • 6.Ludwig M. Diagnosis and therapy of acute prostatitis, epididymitis and orchitis. Andrologia. 2008;40(2):76-80. doi: 10.1111/j.1439-0272.2007.00823.x. [DOI] [PubMed] [Google Scholar]
  • 7.Nistal M, Paniagua R. Non-neoplastic diseases of the testis. Uro-logic Surgical Pathology. 2008;614-755. doi: 10.1016/B978-0-323-01970-5.50014-2. [DOI] [Google Scholar]
  • 8.Roy S, Hooda S, Parwani AV. Idiopathic granulomatous orchitis. Pathol Res Pract. 2011;207(5):275-8. doi: 10.1016/j.prp.2011.02.005. [DOI] [PubMed] [Google Scholar]
  • 9.Matos MJ, Bacelar MT, Pinto P, Ramos I. Genitourinary tuberculosis. Eur J Radiol. 2005;55(2):181-7. doi: 10.1016/j.ejrad.2005.04.016. [DOI] [PubMed] [Google Scholar]
  • 10.Valdelvira Nadal P, Nicolás Torralba JA, Bañón Pérez VJ, López Cubillana P, Server Pastor G, Prieto González A, Gómez Gómez G, García Hernández JA, Martínez Pertusa P, Perez Albacete M. Bru-cellar orchiepididymitis. Actas Urol Esp. 2001;25(2):140-2. Spanish. doi: 10.1016/s0210-4806(01)72589-2. [DOI] [PubMed] [Google Scholar]
  • 11.Gnanadurai R, Fifer H. Mycoplasma genitalium: A Review. Micro-biology (Reading). 2020;166(1):21-29. doi: 10.1099/mic.0.000830. [DOI] [PubMed] [Google Scholar]
  • 12.Jensen JS, Cusini M, Gomberg M, Moi H. 2016 European guideline on Mycoplasma genitalium infections. J Eur Acad Dermatol Venereol. 2016;30(10):1650-1656. doi: 10.1111/jdv.13849. [DOI] [PubMed] [Google Scholar]
  • 13.Baumann L, Cina M, Egli-Gany D, Goutaki M, Halbeisen FS, Lohrer GR, Ali H, Scott P, Low N. Prevalence of Mycoplasma genitalium in different population groups: systematic review and meta-analysis. Sex Transm Infect. 2018;94(4):255-262. doi: 10.1136/sextrans-2017-053384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Piñeiro L, Galán JC, Vall-Mayans M. Infections caused by Chlamydia trachomatis (including lymphogranuloma venereum) and Mycoplasma genitalium. Enferm Infecc Microbiol Clin (Engl Ed). 2019;37(8):525-534. English, Spanish. doi: 10.1016/j.eimc.2019.01.014. [DOI] [PubMed] [Google Scholar]
  • 15.Mycoplasma genitalium en Atención Primaria: Prevalencia y resistance in Santiago de Compostela Health Care Area] . Revista espanola de quimioterapia: publicacion oficial de la Sociedad Española de Quimioterapia vol. 34,5 (2021): 496-499. doi: 10.37201/req/052.2021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Barberá MJ, Fernández-Huerta M, Jensen JS, Caballero E, Andreu A. Mycoplasma genitalium Macrolide and Fluoroquinolone Resistance: Prevalence and Risk Factors Among a 2013-2014 Cohort of Patients in Barcelona, Spain. Sex Transm Dis. 2017. Aug;44(8):457-462. doi: 10.1097/OLQ.0000000000000631. [DOI] [PubMed] [Google Scholar]
  • 17.Ito S, Tsuchiya T, Yasuda M, Yokoi S, Nakano M, Deguchi T. Prevalence of genital mycoplasmas and ureaplasmas in men younger than 40 years-of-age with acute epididymitis. Int J Urol. 2012;19(3):234-8. doi: 10.1111/j.1442-2042.2011.02917.x. [DOI] [PubMed] [Google Scholar]

Articles from Revista Española de Quimioterapia are provided here courtesy of Sociedad Española de Quimioterapia

RESOURCES